
Laboratoires Pierre Fabre SA - Strategic SWOT Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Operational KPI’s, and Recent Trends
Description
Report Summary
Laboratoires Pierre Fabre SA - Strategic SWOT Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Operational KPI’s, and Recent Trends is a comprehensive and easily accessible overview of Laboratoires Pierre Fabre SA 's business operations. It provides a detailed analysis of the company's strategic standing, as well as its position in the industry compared to competitors. The report includes several key features to facilitate decision-making and provide insights into the company's performance.
The report begins with in-depth information about Laboratoires Pierre Fabre SA including key insights, business segments, key executives, locations, products and services, historical events, corporate strategy, and management discussions. This section provides a solid foundation for understanding the company's key attributes.
Next, the report assesses Laboratoires Pierre Fabre SA's strategic standing through various analyses. The ESG spotlight evaluates the company's environmental, social, and governance performance, providing insights into its sustainability efforts and ethical practices. The SWOT analysis examines the company's internal strengths and weaknesses, as well as external opportunities and threats. By integrating these strategic analyses, the report offers a comprehensive understanding of Laboratoires Pierre Fabre SA's overall strategic standing and supports informed decision-making and strategic planning.
Finally, the report includes recent news and deal activities undertaken by Laboratoires Pierre Fabre SA enhancing awareness of the company's business trends, growth perspectives, and more.
Key Highlights
Laboratoires Pierre Fabre SA is a global pharmaceutical and dermo-cosmetics company dedicated to advancing health and well-being through innovation and high-quality products. Founded in 1962, the company has established itself as a leader in dermatology, oncology, and consumer health, offering a wide range of prescription medications, over-the-counter treatments, skincare, haircare solutions, and dietary supplements. With a strong commitment to research and development, Laboratoires Pierre Fabre SA continuously invests in new treatments and technologies to address the evolving needs of patients and consumers.
The company operates across multiple regions, with a strong presence in Europe, North America, and Asia, providing its products and services to millions worldwide. It also collaborates with healthcare professionals, researchers, and pharmaceutical partners to drive innovation in drug development and clinical research. Headquartered in Roubaix, France, Laboratoires Pierre Fabre SA integrates sustainability into its operations, ensuring that its products and practices contribute positively to both human health and the environment.
Laboratoires Pierre Fabre SA in the News:-
Laboratoires Pierre Fabre SA - Strategic SWOT Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Operational KPI’s, and Recent Trends is a comprehensive and easily accessible overview of Laboratoires Pierre Fabre SA 's business operations. It provides a detailed analysis of the company's strategic standing, as well as its position in the industry compared to competitors. The report includes several key features to facilitate decision-making and provide insights into the company's performance.
The report begins with in-depth information about Laboratoires Pierre Fabre SA including key insights, business segments, key executives, locations, products and services, historical events, corporate strategy, and management discussions. This section provides a solid foundation for understanding the company's key attributes.
Next, the report assesses Laboratoires Pierre Fabre SA's strategic standing through various analyses. The ESG spotlight evaluates the company's environmental, social, and governance performance, providing insights into its sustainability efforts and ethical practices. The SWOT analysis examines the company's internal strengths and weaknesses, as well as external opportunities and threats. By integrating these strategic analyses, the report offers a comprehensive understanding of Laboratoires Pierre Fabre SA's overall strategic standing and supports informed decision-making and strategic planning.
Finally, the report includes recent news and deal activities undertaken by Laboratoires Pierre Fabre SA enhancing awareness of the company's business trends, growth perspectives, and more.
Key Highlights
Laboratoires Pierre Fabre SA is a global pharmaceutical and dermo-cosmetics company dedicated to advancing health and well-being through innovation and high-quality products. Founded in 1962, the company has established itself as a leader in dermatology, oncology, and consumer health, offering a wide range of prescription medications, over-the-counter treatments, skincare, haircare solutions, and dietary supplements. With a strong commitment to research and development, Laboratoires Pierre Fabre SA continuously invests in new treatments and technologies to address the evolving needs of patients and consumers.
The company operates across multiple regions, with a strong presence in Europe, North America, and Asia, providing its products and services to millions worldwide. It also collaborates with healthcare professionals, researchers, and pharmaceutical partners to drive innovation in drug development and clinical research. Headquartered in Roubaix, France, Laboratoires Pierre Fabre SA integrates sustainability into its operations, ensuring that its products and practices contribute positively to both human health and the environment.
Laboratoires Pierre Fabre SA in the News:-
- 07-Oct-2024 - Pierre Fabre & Scorpion Therapeutics announce new Phase I/II clinical trial for an innovative treatment in oncology.
- 21-Jun-2024 - Pierre Fabre Laboratories receives the Galien International Prize for EBVALLO
- 12-Jun-2024 - " Green Bioplastics Project " wins 1st prize in the Maud Fontenoy Foundation
- 05-Jun-2024 - Pierre Fabre Laboratories Awarded Responsible Digital Label
- 21-May-2024 - Pierre Fabre Laboratories announce the submission by Atara Biotherapeutics of the biological license application for Tabelecleucel (Tab-cel®) for the treatment of Epstein-Barr virus-associated positive post-transplant lymphoproliferative disease to the FDA (Food and Drug Administration) USA
- Tactical Analysis:- Various strategic frameworks to gain insights into a company's competitive position and operational environment. These analytical tools assist in identifying competitive advantages, potential risks, and areas for improvement and efficiency, enabling companies to make informed tactical decisions.
- Business Strategy:- Contributes to shaping the company's overall direction, goals, and decision-making processes, ensuring long-term success and alignment with stakeholder expectations.
- Company Fundamentals:- These fundamentals offer valuable insights into the company's history, operations, leadership, and geographical presence, aiding in a comprehensive understanding of the organization.
- Competitive Landscape:- An identification of the company's main competitors, providing insights into the competitive landscape it operates in.
- Comprehensive Understanding of the Laboratoires Pierre Fabre SA's internal and external factors through SWOT analysis and Corporate Strategy.
- Strive Strategic Decision Making with various analyses and identifying potential customers and suppliers.
- Mitigate Risk with help of thorough analysis of internal and external factors. Furthermore, develop strategies and contingency plans to address these challenges and minimize their impact on business operations.
- Competitive Benchmarking will help to gain a competitive advantage by understanding industry trends, customer preferences, and best practices.
- Valuable insights from the report enable investors and partners to make informed decisions regarding potential Collaborations, Investments, or Partnerships with the company.
- Laboratoires Pierre Fabre SA PESTLE Analysis
- Laboratoires Pierre Fabre SA Value Chain Analysis
- Laboratoires Pierre Fabre SA Porter's Five Forces Analysis
- Laboratoires Pierre Fabre SA VRIO Analysis
- Laboratoires Pierre Fabre SA BCG Analysis
- Laboratoires Pierre Fabre SA Segmentation, Targeting and Positioning (STP) Analysis
- Laboratoires Pierre Fabre SA Ansoff Matrix Analysis
Table of Contents
95 Pages
- Table of Contents
- Tables
- Charts
- Laboratoires Pierre Fabre SA - Key Company Facts
- Laboratoires Pierre Fabre SA - Company Description
- Laboratoires Pierre Fabre SA - Top Executives
- Laboratoires Pierre Fabre SA - Top Executives Biographies
- Laboratoires Pierre Fabre SA - Head Office & Locations
- Head Office - Country
- Key Subsidiaries
- Key Joint Ventures
- Laboratoires Pierre Fabre SA - Products and Services
- Products
- Services
- Laboratoires Pierre Fabre SA - Historic Events
- Laboratoires Pierre Fabre SA - Company's Management Discussion
- Laboratoires Pierre Fabre SA - Company's Mission and Vision
- Mission
- Vision
- Laboratoires Pierre Fabre SA - Corporate Strategy
- Laboratoires Pierre Fabre SA - Business Description
- Pharmaceutical Segment
- Dermo-Cosmetics and Personal Care Segment
- Consumer Health and Over-the-Counter OTC Segment
- Pharmaceutical Manufacturing and Contract Services Segment
- Laboratoires Pierre Fabre SA - ESG Spotlight
- Environment
- Social
- Corporate Governance
- Laboratoires Pierre Fabre SA - SWOT Analysis
- Overview
- Strengths
- Weaknesses
- Opportunities
- Threats
- Competing Players
- Snapshot of Competing Players
- Beiersdorf AG
- Key Company Facts
- Company Description
- Key Financials
- Share Price Trend - Jan-2024 to May-2025 (Average Share Closing Price)
- Key Financial Ratio Analysis
- L'Oreal SA
- Key Company Facts
- Company Description
- Key Financials
- Share Price Trend - Jan-2024 to May-2025 (Average Share Closing Price)
- Key Financial Ratio Analysis
- Novartis AG
- Key Company Facts
- Company Description
- Novartis AG - SWOT Spotlight
- Key Financials
- Share Price Trend - Jan-2024 to May-2025 (Average Share Closing Price)
- Key Financial Ratio Analysis
- Sanofi S.A.
- Key Company Facts
- Company Description
- Sanofi S.A. - SWOT Spotlight
- Sanofi S.A. - PESTLE Spotlight
- Key Financials
- Share Price Trend - Jan-2024 to May-2025 (Average Share Closing Price)
- Key Financial Ratio Analysis
- Galderma SA
- Key Company Facts
- Company Description
- Laboratoires Pierre Fabre SA - In the News 07-Oct-2024 - Pierre Fabre & Scorpion Therapeutics announce new Phase I/II clinical trial for an innovative treatment in oncology.
- 21-Jun-2024 - Pierre Fabre Laboratories receives the Galien International Prize for EBVALLO
- 12-Jun-2024 - " Green Bioplastics Project " wins 1st prize in the Maud Fontenoy Foundation 05-Jun-2024 - Pierre Fabre Laboratories Awarded Responsible Digital Label
- 10-Jan-2024 - Herve Hoppenot, Incyte CEO, is appointed on the Board of Pierre Fabre Laboratories
- 28-Sep-2023 - Pierre Fabre becomes the first international manufacturing group to be awarded the "Outstanding" level of the Responsibility Europe label delivered by AFNOR Certification
- 20-Jun-2023 - Pierre Fabre unveils its ALL project: the largest international dermatology database. 09-Jun-2023 - PIERRE FABRE INAUGURATES ITS NEW INNOVATION CENTER IN CHINA
- 12-Apr-2023 - Pierre Fabre announces the acquisition of MEME
- Laboratoires Pierre Fabre SA - Key Deals
- 12-Jul-2024 - Pierre Fabre Laboratoires signs a sponsorship agreement with the IHU healthAge In Toulouse
- Appendix
- Definitions
- SWOT Analysis
- PESTLE Analysis
- Value Chain Analysis
- ESG Spotlight
- Research Methodology
- Disclaimer
- Contact Us
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.